1. Home
  2. PRME

PRME

Prime Medicine Inc.

Logo Prime Medicine Inc.

Health Care

Medicinal Chemicals and Botanical Products

Nasdaq

as 04-22-2024 4:00pm EST

$
-
.
-
-
+$
-
.
-
-
+
-
.
-
-
%

Prime Medicine Inc is a biotechnology company committed to delivering genetic therapies to address diseases by deploying gene editing technology, Prime Editing. The Prime Editing technology is a next-generation technology that can search and replace to restore normal genetic function in the genome and can treat a wide spectrum of diseases with high unmet medical needs and efficient and broad gene editing technology.

Founded: 2019 Country:
United States
United States
Employees: N/A City: CAMBRIDGE
Market Cap: 652.5M IPO Year: 2022
Target Price: $17.88 AVG Volume (30 days): 698.6K
Analyst Decision: Strong Buy Number of Analysts: 9
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -2.18 EPS Growth: N/A
52 Week Low/High: $5.48 - $17.20 Next Earning Date: 05-09-2024
Revenue: N/A Revenue Growth: N/A
Revenue Growth (this year): N/A Revenue Growth (next year): -31.94%

Share on Social Networks: